Global Hormone Sensitive Prostate Cancer Drugs Market Insights, Forecast to 2030

TABLE OF CONTENTS

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Hormone Sensitive Prostate Cancer Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
  • 1.2.2 Androgen Ablation Therapy
  • 1.2.3 Anti-androgens
  • 1.2.4 Chemotherapy
  • 1.2.5 Targeted Therapy
• 1.3 Market by Application
  • 1.3.1 Global Hormone Sensitive Prostate Cancer Drugs Market Share by Application: 2019 VS 2023 VS 2030
  • 1.3.2 Hospitals
  • 1.3.3 Clinics
  • 1.3.4 Other
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Hormone Sensitive Prostate Cancer Drugs Market Perspective (2019-2030)
• 2.2 Global Hormone Sensitive Prostate Cancer Drugs Growth Trends by Region
  • 2.2.1 Global Hormone Sensitive Prostate Cancer Drugs Market Size by Region: 2019 VS 2023 VS 2030
  • 2.2.2 Hormone Sensitive Prostate Cancer Drugs Historic Market Size by Region (2019-2024)
  • 2.2.3 Hormone Sensitive Prostate Cancer Drugs Forecasted Market Size by Region (2025-2030)
• 2.3 Hormone Sensitive Prostate Cancer Drugs Market Dynamics
  • 2.3.1 Hormone Sensitive Prostate Cancer Drugs Industry Trends
  • 2.3.2 Hormone Sensitive Prostate Cancer Drugs Market Drivers
  • 2.3.3 Hormone Sensitive Prostate Cancer Drugs Market Challenges
  • 2.3.4 Hormone Sensitive Prostate Cancer Drugs Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Revenue Hormone Sensitive Prostate Cancer Drugs by Players
  • 3.1.1 Global Hormone Sensitive Prostate Cancer Drugs Revenue by Players (2019-2024)
  • 3.1.2 Global Hormone Sensitive Prostate Cancer Drugs Revenue Market Share by Players (2019-2024)
• 3.2 Global Hormone Sensitive Prostate Cancer Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.3 Global Key Players of Hormone Sensitive Prostate Cancer Drugs, Ranking by Revenue, 2022 VS 2023 VS 2024
• 3.4 Global Hormone Sensitive Prostate Cancer Drugs Market Concentration Ratio
  • 3.4.1 Global Hormone Sensitive Prostate Cancer Drugs Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Hormone Sensitive Prostate Cancer Drugs Revenue in 2023
• 3.5 Global Key Players of Hormone Sensitive Prostate Cancer Drugs Head office and Area Served
• 3.6 Global Key Players of Hormone Sensitive Prostate Cancer Drugs, Product and Application
• 3.7 Global Key Players of Hormone Sensitive Prostate Cancer Drugs, Date of Enter into This Industry
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Hormone Sensitive Prostate Cancer Drugs Breakdown Data by Type

• 4.1 Global Hormone Sensitive Prostate Cancer Drugs Historic Market Size by Type (2019-2024)
• 4.2 Global Hormone Sensitive Prostate Cancer Drugs Forecasted Market Size by Type (2025-2030)

5 Hormone Sensitive Prostate Cancer Drugs Breakdown Data by Application

• 5.1 Global Hormone Sensitive Prostate Cancer Drugs Historic Market Size by Application (2019-2024)
• 5.2 Global Hormone Sensitive Prostate Cancer Drugs Forecasted Market Size by Application (2025-2030)

6 North America

• 6.1 North America Hormone Sensitive Prostate Cancer Drugs Market Size (2019-2030)
• 6.2 North America Hormone Sensitive Prostate Cancer Drugs Market Size by Type
  • 6.2.1 North America Hormone Sensitive Prostate Cancer Drugs Market Size by Type (2019-2024)
  • 6.2.2 North America Hormone Sensitive Prostate Cancer Drugs Market Size by Type (2025-2030)
  • 6.2.3 North America Hormone Sensitive Prostate Cancer Drugs Market Share by Type (2019-2030)
• 6.3 North America Hormone Sensitive Prostate Cancer Drugs Market Size by Application
  • 6.3.1 North America Hormone Sensitive Prostate Cancer Drugs Market Size by Application (2019-2024)
  • 6.3.2 North America Hormone Sensitive Prostate Cancer Drugs Market Size by Application (2025-2030)
  • 6.3.3 North America Hormone Sensitive Prostate Cancer Drugs Market Share by Application (2019-2030)
• 6.4 North America Hormone Sensitive Prostate Cancer Drugs Market Size by Country
  • 6.4.1 North America Hormone Sensitive Prostate Cancer Drugs Market Size by Country: 2019 VS 2023 VS 2030
  • 6.4.2 North America Hormone Sensitive Prostate Cancer Drugs Market Size by Country (2019-2024)
  • 6.4.3 North America Hormone Sensitive Prostate Cancer Drugs Market Share by Country (2025-2030)
  • 6.4.4 United States
  • 6.4.5 Canada

7 Europe

• 7.1 Europe Hormone Sensitive Prostate Cancer Drugs Market Size (2019-2030)
• 7.2 Europe Hormone Sensitive Prostate Cancer Drugs Market Size by Type
  • 7.2.1 Europe Hormone Sensitive Prostate Cancer Drugs Market Size by Type (2019-2024)
  • 7.2.2 Europe Hormone Sensitive Prostate Cancer Drugs Market Size by Type (2025-2030)
  • 7.2.3 Europe Hormone Sensitive Prostate Cancer Drugs Market Share by Type (2019-2030)
• 7.3 Europe Hormone Sensitive Prostate Cancer Drugs Market Size by Application
  • 7.3.1 Europe Hormone Sensitive Prostate Cancer Drugs Market Size by Application (2019-2024)
  • 7.3.2 Europe Hormone Sensitive Prostate Cancer Drugs Market Size by Application (2025-2030)
  • 7.3.3 Europe Hormone Sensitive Prostate Cancer Drugs Market Share by Application (2019-2030)
• 7.4 Europe Hormone Sensitive Prostate Cancer Drugs Market Size by Country
  • 7.4.1 Europe Hormone Sensitive Prostate Cancer Drugs Market Size by Country: 2019 VS 2023 VS 2030
  • 7.4.2 Europe Hormone Sensitive Prostate Cancer Drugs Market Size by Country (2019-2024)
  • 7.4.3 Europe Hormone Sensitive Prostate Cancer Drugs Market Size by Country (2025-2030)
  • 7.4.4 Germany
  • 7.4.5 France
  • 7.4.6 U.K.
  • 7.4.7 Italy
  • 7.4.8 Russia
  • 7.4.9 Nordic Countries

8 China

• 8.1 China Hormone Sensitive Prostate Cancer Drugs Market Size (2019-2030)
• 8.2 China Hormone Sensitive Prostate Cancer Drugs Market Size by Type
  • 8.2.1 China Hormone Sensitive Prostate Cancer Drugs Market Size by Type (2019-2024)
  • 8.2.2 China Hormone Sensitive Prostate Cancer Drugs Market Size by Type (2025-2030)
  • 8.2.3 China Hormone Sensitive Prostate Cancer Drugs Market Share by Type (2019-2030)
• 8.3 China Hormone Sensitive Prostate Cancer Drugs Market Size by Application
  • 8.3.1 China Hormone Sensitive Prostate Cancer Drugs Market Size by Application (2019-2024)
  • 8.3.2 China Hormone Sensitive Prostate Cancer Drugs Market Size by Application (2025-2030)
  • 8.3.3 China Hormone Sensitive Prostate Cancer Drugs Market Share by Application (2019-2030)

9 Asia (excluding China)

• 9.1 Asia Hormone Sensitive Prostate Cancer Drugs Market Size (2019-2030)
• 9.2 Asia Hormone Sensitive Prostate Cancer Drugs Market Size by Type
  • 9.2.1 Asia Hormone Sensitive Prostate Cancer Drugs Market Size by Type (2019-2024)
  • 9.2.2 Asia Hormone Sensitive Prostate Cancer Drugs Market Size by Type (2025-2030)
  • 9.2.3 Asia Hormone Sensitive Prostate Cancer Drugs Market Share by Type (2019-2030)
• 9.3 Asia Hormone Sensitive Prostate Cancer Drugs Market Size by Application
  • 9.3.1 Asia Hormone Sensitive Prostate Cancer Drugs Market Size by Application (2019-2024)
  • 9.3.2 Asia Hormone Sensitive Prostate Cancer Drugs Market Size by Application (2025-2030)
  • 9.3.3 Asia Hormone Sensitive Prostate Cancer Drugs Market Share by Application (2019-2030)
• 9.4 Asia Hormone Sensitive Prostate Cancer Drugs Market Size by Region
  • 9.4.1 Asia Hormone Sensitive Prostate Cancer Drugs Market Size by Region: 2019 VS 2023 VS 2030
  • 9.4.2 Asia Hormone Sensitive Prostate Cancer Drugs Market Size by Region (2019-2024)
  • 9.4.3 Asia Hormone Sensitive Prostate Cancer Drugs Market Size by Region (2025-2030)
  • 9.4.4 Japan
  • 9.4.5 South Korea
  • 9.4.6 China Taiwan
  • 9.4.7 Southeast Asia
  • 9.4.8 India
  • 9.4.9 Australia

10 Middle East, Africa, and Latin America

• 10.1 Middle East, Africa, and Latin America Hormone Sensitive Prostate Cancer Drugs Market Size (2019-2030)
• 10.2 Middle East, Africa, and Latin America Hormone Sensitive Prostate Cancer Drugs Market Size by Type
  • 10.2.1 Middle East, Africa, and Latin America Hormone Sensitive Prostate Cancer Drugs Market Size by Type (2019-2024)
  • 10.2.2 Middle East, Africa, and Latin America Hormone Sensitive Prostate Cancer Drugs Market Size by Type (2025-2030)
  • 10.2.3 Middle East, Africa, and Latin America Hormone Sensitive Prostate Cancer Drugs Market Share by Type (2019-2030)
• 10.3 Middle East, Africa, and Latin America Hormone Sensitive Prostate Cancer Drugs Market Size by Application
  • 10.3.1 Middle East, Africa, and Latin America Hormone Sensitive Prostate Cancer Drugs Market Size by Application (2019-2024)
  • 10.3.2 Middle East, Africa, and Latin America Hormone Sensitive Prostate Cancer Drugs Market Size by Application (2025-2030)
  • 10.3.3 Middle East, Africa, and Latin America Hormone Sensitive Prostate Cancer Drugs Market Share by Application (2019-2030)
• 10.4 Middle East, Africa, and Latin America Hormone Sensitive Prostate Cancer Drugs Market Size by Country
  • 10.4.1 Middle East, Africa, and Latin America Hormone Sensitive Prostate Cancer Drugs Market Size by Country: 2019 VS 2023 VS 2030
  • 10.4.2 Middle East, Africa, and Latin America Hormone Sensitive Prostate Cancer Drugs Market Size by Country (2019-2024)
  • 10.4.3 Middle East, Africa, and Latin America Hormone Sensitive Prostate Cancer Drugs Market Size by Country (2025-2030)
  • 10.4.4 Brazil
  • 10.4.5 Mexico
  • 10.4.6 Turkey
  • 10.4.7 Saudi Arabia
  • 10.4.8 Israel
  • 10.4.9 GCC Countries

11 Key Players Profiles

• 11.1 Novartis
  • 11.1.1 Novartis Company Details
  • 11.1.2 Novartis Business Overview
  • 11.1.3 Novartis Hormone Sensitive Prostate Cancer Drugs Introduction
  • 11.1.4 Novartis Revenue in Hormone Sensitive Prostate Cancer Drugs Business (2019-2024)
  • 11.1.5 Novartis Recent Development
• 11.2 Merc & Co.
  • 11.2.1 Merc & Co. Company Details
  • 11.2.2 Merc & Co. Business Overview
  • 11.2.3 Merc & Co. Hormone Sensitive Prostate Cancer Drugs Introduction
  • 11.2.4 Merc & Co. Revenue in Hormone Sensitive Prostate Cancer Drugs Business (2019-2024)
  • 11.2.5 Merc & Co. Recent Development
• 11.3 Bristol-Myers
  • 11.3.1 Bristol-Myers Company Details
  • 11.3.2 Bristol-Myers Business Overview
  • 11.3.3 Bristol-Myers Hormone Sensitive Prostate Cancer Drugs Introduction
  • 11.3.4 Bristol-Myers Revenue in Hormone Sensitive Prostate Cancer Drugs Business (2019-2024)
  • 11.3.5 Bristol-Myers Recent Development
• 11.4 Dendreon Corporation
  • 11.4.1 Dendreon Corporation Company Details
  • 11.4.2 Dendreon Corporation Business Overview
  • 11.4.3 Dendreon Corporation Hormone Sensitive Prostate Cancer Drugs Introduction
  • 11.4.4 Dendreon Corporation Revenue in Hormone Sensitive Prostate Cancer Drugs Business (2019-2024)
  • 11.4.5 Dendreon Corporation Recent Development
• 11.5 GlaxoSmithKline
  • 11.5.1 GlaxoSmithKline Company Details
  • 11.5.2 GlaxoSmithKline Business Overview
  • 11.5.3 GlaxoSmithKline Hormone Sensitive Prostate Cancer Drugs Introduction
  • 11.5.4 GlaxoSmithKline Revenue in Hormone Sensitive Prostate Cancer Drugs Business (2019-2024)
  • 11.5.5 GlaxoSmithKline Recent Development
• 11.6 Ferring
  • 11.6.1 Ferring Company Details
  • 11.6.2 Ferring Business Overview
  • 11.6.3 Ferring Hormone Sensitive Prostate Cancer Drugs Introduction
  • 11.6.4 Ferring Revenue in Hormone Sensitive Prostate Cancer Drugs Business (2019-2024)
  • 11.6.5 Ferring Recent Development
• 11.7 Roche
  • 11.7.1 Roche Company Details
  • 11.7.2 Roche Business Overview
  • 11.7.3 Roche Hormone Sensitive Prostate Cancer Drugs Introduction
  • 11.7.4 Roche Revenue in Hormone Sensitive Prostate Cancer Drugs Business (2019-2024)
  • 11.7.5 Roche Recent Development
• 11.8 Celgen
  • 11.8.1 Celgen Company Details
  • 11.8.2 Celgen Business Overview
  • 11.8.3 Celgen Hormone Sensitive Prostate Cancer Drugs Introduction
  • 11.8.4 Celgen Revenue in Hormone Sensitive Prostate Cancer Drugs Business (2019-2024)
  • 11.8.5 Celgen Recent Development
• 11.9 Amgen
  • 11.9.1 Amgen Company Details
  • 11.9.2 Amgen Business Overview
  • 11.9.3 Amgen Hormone Sensitive Prostate Cancer Drugs Introduction
  • 11.9.4 Amgen Revenue in Hormone Sensitive Prostate Cancer Drugs Business (2019-2024)
  • 11.9.5 Amgen Recent Development
• 11.10 Teva
  • 11.10.1 Teva Company Details
  • 11.10.2 Teva Business Overview
  • 11.10.3 Teva Hormone Sensitive Prostate Cancer Drugs Introduction
  • 11.10.4 Teva Revenue in Hormone Sensitive Prostate Cancer Drugs Business (2019-2024)
  • 11.10.5 Teva Recent Development
• 11.11 Bayer
  • 11.11.1 Bayer Company Details
  • 11.11.2 Bayer Business Overview
  • 11.11.3 Bayer Hormone Sensitive Prostate Cancer Drugs Introduction
  • 11.11.4 Bayer Revenue in Hormone Sensitive Prostate Cancer Drugs Business (2019-2024)
  • 11.11.5 Bayer Recent Development
• 11.12 Pfizer
  • 11.12.1 Pfizer Company Details
  • 11.12.2 Pfizer Business Overview
  • 11.12.3 Pfizer Hormone Sensitive Prostate Cancer Drugs Introduction
  • 11.12.4 Pfizer Revenue in Hormone Sensitive Prostate Cancer Drugs Business (2019-2024)
  • 11.12.5 Pfizer Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
    • 13.1.1.1 Research Programs/Design
    • 13.1.1.2 Market Size Estimation
    • 13.1.1.3 Market Breakdown and Data Triangulation
  • 13.1.2 Data Source
    • 13.1.2.1 Secondary Sources
    • 13.1.2.2 Primary Sources
• 13.2 Author Details
• 13.3 Disclaimer

List of Tables

Table 1. Global Hormone Sensitive Prostate Cancer Drugs Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Androgen Ablation Therapy

Table 3. Key Players of Anti-androgens

Table 4. Key Players of Chemotherapy

Table 5. Key Players of Targeted Therapy

Table 6. Global Hormone Sensitive Prostate Cancer Drugs Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Hormone Sensitive Prostate Cancer Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Hormone Sensitive Prostate Cancer Drugs Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global Hormone Sensitive Prostate Cancer Drugs Market Share by Region (2019-2024)

Table 10. Global Hormone Sensitive Prostate Cancer Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global Hormone Sensitive Prostate Cancer Drugs Market Share by Region (2025-2030)

Table 12. Hormone Sensitive Prostate Cancer Drugs Market Trends

Table 13. Hormone Sensitive Prostate Cancer Drugs Market Drivers

Table 14. Hormone Sensitive Prostate Cancer Drugs Market Challenges

Table 15. Hormone Sensitive Prostate Cancer Drugs Market Restraints

Table 16. Global Hormone Sensitive Prostate Cancer Drugs Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global Hormone Sensitive Prostate Cancer Drugs Market Share by Players (2019-2024)

Table 18. Global Top Hormone Sensitive Prostate Cancer Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hormone Sensitive Prostate Cancer Drugs as of 2023)

Table 19. Global Hormone Sensitive Prostate Cancer Drugs Industry Ranking 2022 VS 2023

Table 20. Global 5 Largest Players Market Share by Hormone Sensitive Prostate Cancer Drugs Revenue (CR5 and HHI) & (2019-2024)

Table 21. Global Key Players of Hormone Sensitive Prostate Cancer Drugs, Headquarters and Area Served

Table 22. Global Key Players of Hormone Sensitive Prostate Cancer Drugs, Product and Application

Table 23. Global Key Players of Hormone Sensitive Prostate Cancer Drugs, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Hormone Sensitive Prostate Cancer Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global Hormone Sensitive Prostate Cancer Drugs Revenue Market Share by Type (2019-2024)

Table 27. Global Hormone Sensitive Prostate Cancer Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global Hormone Sensitive Prostate Cancer Drugs Revenue Market Share by Type (2025-2030)

Table 29. Global Hormone Sensitive Prostate Cancer Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global Hormone Sensitive Prostate Cancer Drugs Revenue Market Share by Application (2019-2024)

Table 31. Global Hormone Sensitive Prostate Cancer Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global Hormone Sensitive Prostate Cancer Drugs Revenue Market Share by Application (2025-2030)

Table 33. North America Hormone Sensitive Prostate Cancer Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 34. North America Hormone Sensitive Prostate Cancer Drugs Market Size by Type (2025-2030) & (US$ Million)

Table 35. North America Hormone Sensitive Prostate Cancer Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 36. North America Hormone Sensitive Prostate Cancer Drugs Market Size by Application (2025-2030) & (US$ Million)

Table 37. North America Hormone Sensitive Prostate Cancer Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. North America Hormone Sensitive Prostate Cancer Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 39. North America Hormone Sensitive Prostate Cancer Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 40. Europe Hormone Sensitive Prostate Cancer Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 41. Europe Hormone Sensitive Prostate Cancer Drugs Market Size by Type (2025-2030) & (US$ Million)

Table 42. Europe Hormone Sensitive Prostate Cancer Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 43. Europe Hormone Sensitive Prostate Cancer Drugs Market Size by Application (2025-2030) & (US$ Million)

Table 44. Europe Hormone Sensitive Prostate Cancer Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Europe Hormone Sensitive Prostate Cancer Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 46. Europe Hormone Sensitive Prostate Cancer Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 47. China Hormone Sensitive Prostate Cancer Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 48. China Hormone Sensitive Prostate Cancer Drugs Market Size by Type (2025-2030) & (US$ Million)

Table 49. China Hormone Sensitive Prostate Cancer Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 50. China Hormone Sensitive Prostate Cancer Drugs Market Size by Application (2025-2030) & (US$ Million)

Table 51. Asia Hormone Sensitive Prostate Cancer Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 52. Asia Hormone Sensitive Prostate Cancer Drugs Market Size by Type (2025-2030) & (US$ Million)

Table 53. Asia Hormone Sensitive Prostate Cancer Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 54. Asia Hormone Sensitive Prostate Cancer Drugs Market Size by Application (2025-2030) & (US$ Million)

Table 55. Asia Hormone Sensitive Prostate Cancer Drugs Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 56. Asia Hormone Sensitive Prostate Cancer Drugs Market Size by Region (2019-2024) & (US$ Million)

Table 57. Asia Hormone Sensitive Prostate Cancer Drugs Market Size by Region (2025-2030) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Hormone Sensitive Prostate Cancer Drugs Market Size by Type (2019-2024) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Hormone Sensitive Prostate Cancer Drugs Market Size by Type (2025-2030) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Hormone Sensitive Prostate Cancer Drugs Market Size by Application (2019-2024) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Hormone Sensitive Prostate Cancer Drugs Market Size by Application (2025-2030) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Hormone Sensitive Prostate Cancer Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 63. Middle East, Africa, and Latin America Hormone Sensitive Prostate Cancer Drugs Market Size by Country (2019-2024) & (US$ Million)

Table 64. Middle East, Africa, and Latin America Hormone Sensitive Prostate Cancer Drugs Market Size by Country (2025-2030) & (US$ Million)

Table 65. Novartis Company Details

Table 66. Novartis Business Overview

Table 67. Novartis Hormone Sensitive Prostate Cancer Drugs Product

Table 68. Novartis Revenue in Hormone Sensitive Prostate Cancer Drugs Business (2019-2024) & (US$ Million)

Table 69. Novartis Recent Development

Table 70. Merc & Co. Company Details

Table 71. Merc & Co. Business Overview

Table 72. Merc & Co. Hormone Sensitive Prostate Cancer Drugs Product

Table 73. Merc & Co. Revenue in Hormone Sensitive Prostate Cancer Drugs Business (2019-2024) & (US$ Million)

Table 74. Merc & Co. Recent Development

Table 75. Bristol-Myers Company Details

Table 76. Bristol-Myers Business Overview

Table 77. Bristol-Myers Hormone Sensitive Prostate Cancer Drugs Product

Table 78. Bristol-Myers Revenue in Hormone Sensitive Prostate Cancer Drugs Business (2019-2024) & (US$ Million)

Table 79. Bristol-Myers Recent Development

Table 80. Dendreon Corporation Company Details

Table 81. Dendreon Corporation Business Overview

Table 82. Dendreon Corporation Hormone Sensitive Prostate Cancer Drugs Product

Table 83. Dendreon Corporation Revenue in Hormone Sensitive Prostate Cancer Drugs Business (2019-2024) & (US$ Million)

Table 84. Dendreon Corporation Recent Development

Table 85. GlaxoSmithKline Company Details

Table 86. GlaxoSmithKline Business Overview

Table 87. GlaxoSmithKline Hormone Sensitive Prostate Cancer Drugs Product

Table 88. GlaxoSmithKline Revenue in Hormone Sensitive Prostate Cancer Drugs Business (2019-2024) & (US$ Million)

Table 89. GlaxoSmithKline Recent Development

Table 90. Ferring Company Details

Table 91. Ferring Business Overview

Table 92. Ferring Hormone Sensitive Prostate Cancer Drugs Product

Table 93. Ferring Revenue in Hormone Sensitive Prostate Cancer Drugs Business (2019-2024) & (US$ Million)

Table 94. Ferring Recent Development

Table 95. Roche Company Details

Table 96. Roche Business Overview

Table 97. Roche Hormone Sensitive Prostate Cancer Drugs Product

Table 98. Roche Revenue in Hormone Sensitive Prostate Cancer Drugs Business (2019-2024) & (US$ Million)

Table 99. Roche Recent Development

Table 100. Celgen Company Details

Table 101. Celgen Business Overview

Table 102. Celgen Hormone Sensitive Prostate Cancer Drugs Product

Table 103. Celgen Revenue in Hormone Sensitive Prostate Cancer Drugs Business (2019-2024) & (US$ Million)

Table 104. Celgen Recent Development

Table 105. Amgen Company Details

Table 106. Amgen Business Overview

Table 107. Amgen Hormone Sensitive Prostate Cancer Drugs Product

Table 108. Amgen Revenue in Hormone Sensitive Prostate Cancer Drugs Business (2019-2024) & (US$ Million)

Table 109. Amgen Recent Development

Table 110. Teva Company Details

Table 111. Teva Business Overview

Table 112. Teva Hormone Sensitive Prostate Cancer Drugs Product

Table 113. Teva Revenue in Hormone Sensitive Prostate Cancer Drugs Business (2019-2024) & (US$ Million)

Table 114. Teva Recent Development

Table 115. Bayer Company Details

Table 116. Bayer Business Overview

Table 117. Bayer Hormone Sensitive Prostate Cancer Drugs Product

Table 118. Bayer Revenue in Hormone Sensitive Prostate Cancer Drugs Business (2019-2024) & (US$ Million)

Table 119. Bayer Recent Development

Table 120. Pfizer Company Details

Table 121. Pfizer Business Overview

Table 122. Pfizer Hormone Sensitive Prostate Cancer Drugs Product

Table 123. Pfizer Revenue in Hormone Sensitive Prostate Cancer Drugs Business (2019-2024) & (US$ Million)

Table 124. Pfizer Recent Development

Table 125. Research Programs/Design for This Report

Table 126. Key Data Information from Secondary Sources

Table 127. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Hormone Sensitive Prostate Cancer Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Hormone Sensitive Prostate Cancer Drugs Market Share by Type: 2023 VS 2030

Figure 3. Androgen Ablation Therapy Features

Figure 4. Anti-androgens Features

Figure 5. Chemotherapy Features

Figure 6. Targeted Therapy Features

Figure 7. Global Hormone Sensitive Prostate Cancer Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 8. Global Hormone Sensitive Prostate Cancer Drugs Market Share by Application: 2023 VS 2030

Figure 9. Hospitals Case Studies

Figure 10. Clinics Case Studies

Figure 11. Other Case Studies

Figure 12. Hormone Sensitive Prostate Cancer Drugs Report Years Considered

Figure 13. Global Hormone Sensitive Prostate Cancer Drugs Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global Hormone Sensitive Prostate Cancer Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Hormone Sensitive Prostate Cancer Drugs Market Share by Region: 2023 VS 2030

Figure 16. Global Hormone Sensitive Prostate Cancer Drugs Market Share by Players in 2023

Figure 17. Global Top Hormone Sensitive Prostate Cancer Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hormone Sensitive Prostate Cancer Drugs as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by Hormone Sensitive Prostate Cancer Drugs Revenue in 2023

Figure 19. North America Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America Hormone Sensitive Prostate Cancer Drugs Market Share by Type (2019-2030)

Figure 21. North America Hormone Sensitive Prostate Cancer Drugs Market Share by Application (2019-2030)

Figure 22. North America Hormone Sensitive Prostate Cancer Drugs Market Share by Country (2019-2030)

Figure 23. United States Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Canada Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Europe Hormone Sensitive Prostate Cancer Drugs Market Share by Type (2019-2030)

Figure 27. Europe Hormone Sensitive Prostate Cancer Drugs Market Share by Application (2019-2030)

Figure 28. Europe Hormone Sensitive Prostate Cancer Drugs Market Share by Country (2019-2030)

Figure 29. Germany Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. France Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. U.K. Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Italy Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Russia Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Nordic Countries Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. China Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. China Hormone Sensitive Prostate Cancer Drugs Market Share by Type (2019-2030)

Figure 37. China Hormone Sensitive Prostate Cancer Drugs Market Share by Application (2019-2030)

Figure 38. Asia Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Asia Hormone Sensitive Prostate Cancer Drugs Market Share by Type (2019-2030)

Figure 40. Asia Hormone Sensitive Prostate Cancer Drugs Market Share by Application (2019-2030)

Figure 41. Asia Hormone Sensitive Prostate Cancer Drugs Market Share by Region (2019-2030)

Figure 42. Japan Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. South Korea Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. China Taiwan Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Southeast Asia Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. India Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Australia Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Middle East, Africa, and Latin America Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. Middle East, Africa, and Latin America Hormone Sensitive Prostate Cancer Drugs Market Share by Type (2019-2030)

Figure 50. Middle East, Africa, and Latin America Hormone Sensitive Prostate Cancer Drugs Market Share by Application (2019-2030)

Figure 51. Middle East, Africa, and Latin America Hormone Sensitive Prostate Cancer Drugs Market Share by Country (2019-2030)

Figure 52. Brazil Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Mexico Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Turkey Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Saudi Arabia Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Israel Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. GCC Countries Hormone Sensitive Prostate Cancer Drugs Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 58. Novartis Revenue Growth Rate in Hormone Sensitive Prostate Cancer Drugs Business (2019-2024)

Figure 59. Merc & Co. Revenue Growth Rate in Hormone Sensitive Prostate Cancer Drugs Business (2019-2024)

Figure 60. Bristol-Myers Revenue Growth Rate in Hormone Sensitive Prostate Cancer Drugs Business (2019-2024)

Figure 61. Dendreon Corporation Revenue Growth Rate in Hormone Sensitive Prostate Cancer Drugs Business (2019-2024)

Figure 62. GlaxoSmithKline Revenue Growth Rate in Hormone Sensitive Prostate Cancer Drugs Business (2019-2024)

Figure 63. Ferring Revenue Growth Rate in Hormone Sensitive Prostate Cancer Drugs Business (2019-2024)

Figure 64. Roche Revenue Growth Rate in Hormone Sensitive Prostate Cancer Drugs Business (2019-2024)

Figure 65. Celgen Revenue Growth Rate in Hormone Sensitive Prostate Cancer Drugs Business (2019-2024)

Figure 66. Amgen Revenue Growth Rate in Hormone Sensitive Prostate Cancer Drugs Business (2019-2024)

Figure 67. Teva Revenue Growth Rate in Hormone Sensitive Prostate Cancer Drugs Business (2019-2024)

Figure 68. Bayer Revenue Growth Rate in Hormone Sensitive Prostate Cancer Drugs Business (2019-2024)

Figure 69. Pfizer Revenue Growth Rate in Hormone Sensitive Prostate Cancer Drugs Business (2019-2024)

Figure 70. Bottom-up and Top-down Approaches for This Report

Figure 71. Data Triangulation

Figure 72. Key Executives Interviewed